Trial intelligence / Profile preview

Antibody response in healthcare workers vaccinated with live-attenuated recombinant Japanese encephalitis chimeric vaccine

TCTR20151203001Recruiting

Sponsor
Sanofi
Start
Oct 2015
Countries
1
01

Overview

Open-label, single-arm trial in Japanese encephalitis (JE), sponsored by Sanofi. Primary endpoint: Antibody response. Started Oct 2015; status: recruiting.

02

Conditions

Japanese encephalitis (JE)

Beyond the preview

Go deeper on TCTR20151203001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20151203001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call